- Home
- TLRY vs CHY Comparison
TLRY vs CHY Comparison
Compare TLRY & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.51
Company Overview
Basic Information| Metric | TLRY | CHY |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 1.0B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | CHY |
|---|---|---|
| Price | $5.51 | $13.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $72.33 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 240.3K |
| Earning Date | 04-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $10.32 |
| 52 Week High | $15.70 | $13.23 |
Technical Indicators
Market Signals| Indicator | TLRY | CHY |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 64.88 |
| Support Level | $5.09 | $11.28 |
| Resistance Level | $7.01 | N/A |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 68.95 | 96.31 |
Price Performance
Historical Comparison TLRY
CHY
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.